Overview
Patients with functional mitral regurgitation classified as moderate to severe (3+) or severe (4+) that are symptomatic (NYHA Class II-IV) will be evaluated for treatment using the CathHELIX Transcatheter Mitral Annuloplasty System.
Eligibility
Inclusion Criteria:
- Moderate to severe (3+) or severe (4+) functional mitral regurgitation
- Left ventricular ejection fraction ≥30%
- Symptomatic New York Heart Association (NYHA) Class II to IV).
Exclusion Criteria:
- Oxygen dependent for COPD
- Active or suspected endocarditis
- Severe symptomatic carotid stenosis
- Has undergone heart transplantation.
- Severe calcification of the mitral annulus or leaflets
- Coronary sinus anatomy that may preclude proper treatment with the device